Live attenuated vaccine · VDDBV0486
| NCT ID | Phase | Disease / Condition |
|---|---|---|
| NCT02724852 | Approved | HIV Infections |
| NCT02724852 | Approved | Measles |
| NCT00109278 | Phase 2 | Measles; Mumps; Rubella; Varicella |
| NCT00092430 | Phase 3 | Measles; Mumps; Rubella; Varicella |
| NCT04428359 | — | Measles; Mumps; Rubella; Varicella |
| NCT02724852 | Approved | Varicella; Rubella; Mumps; Measles |
| NCT03368495 | Approved | Varicella; Rubella; Mumps; Measles |
| NCT02325310 | Approved | Varicella; Rubella; Mumps; Measles |
| NCT00092391 | Phase 3 | Varicella; Rubella; Mumps; Measles |
| NCT00092404 | Phase 2 | Varicella; Rubella; Mumps; Measles |
| NCT01777529 | Approved | Varicella; Rubella; Mumps; Measles |
| NCT03853785 | Phase 3 | Varicella; Rubella; Mumps; Measles |
| NCT00109278 | Phase 2 | Varicella; Rubella; Mumps; Measles |
| NCT00092430 | Phase 3 | Varicella; Rubella; Mumps; Measles |
| NCT04428359 | — | Varicella; Rubella; Mumps; Measles |
| NCT03183765 | Approved | Varicella; Rubella; Mumps; Measles |